Search

You searched for "information"

1112 results found
European Urology journal front cover.

The future of bladder-sparing therapy is bright

2 July 2025 | | URO - Urologic Oncology
Trimodal therapy (TMT), combining optimal transurethral resection of bladder tumour (TURBT) and concurrent chemoradiotherapy, has garnered significant attention for managing muscle-invasive bladder cancer (MIBC). This approach offers the potential for bladder preservation while delivering oncological outcomes comparable to radical cystectomy....

Mount Sinai Urology Chair Receives Honorary Fellowship From Prestigious Royal College

8 June 2026 | Urology News
Ash K. Tewari, MBBS, MCh, FRCS (Hon.), DSc (Hon.), Chair of the Department of Urology at the Icahn School of Medicine at Mount Sinai in New York City and Director of the Center of Excellence for Prostate Cancer at the...

Bike4TUF goes local to raise vital funds and support patients

7 October 2020 |
There was no stopping urologists from raising vital funds for charity as they cycled more than 2000 miles to support The Urology Foundation (TUF). The annual Bike4TUF event saw 24 participants cycle in teams of six across Manchester, Canterbury, London,...

Action Bladder Cancer UK awards grants for bladder cancer research

5 September 2024 | URO - Urologic Oncology
Action Bladder Cancer UK has granted funding to enable vital research into bladder cancer as part of its annual ABC UK Improving Outcomes for Patients Programme (https://actionbladdercanceruk.org/abc-uk-grants/). The five grant recipients will undertake significant studies, ranging from the analysis of...
Journal of Pediatric Urology cover image.

Long-term consequences of posterior urethral valves

1 May 2014 | | URO - Paediatrics
These two papers give a very good summary of the long-term effects of posterior urethral valves (PUV) into adulthood and are worth a read. Pereira et al. It is well known that the consequences of posterior urethral valves extend well...

New eco-friendly home delivery service launched!

3 March 2021 | Research & Development
Optimum Medical celebrate the launch of their new eco-friendly home delivery service, Vyne. Vyne is here to provide a better, greener and easier way of getting...

Opening up about incontinence

21 September 2021 | Research & Development
This year, the EAU’s Urology Week is shining the spotlight on incontinence because it is still a taboo subject, with many people struggling to talk to a health professional, partner or even a friend about it.

Action Bladder Cancer UK launches learning module for primary care

16 October 2024 | Charities
Action Bladder Cancer UK has launched a new online learning module for primary care, to help healthcare professionals improve their knowledge of bladder cancer. Bladder cancer is not a rare cancer. In the UK alone, over 23,000 people are diagnosed...

Introducing Caress Flow, a painless, effective, and affordable treatment for intimate health

14 November 2024 | Company Profiles, Research & Development
Caress Flow, a groundbreaking treatment that promises to transform the management of vaginal pathologies, is now available in the UK. The innovative therapy offers a holistic, painless solution to a range of vaginal symptoms, with clinical evidence demonstrating significant benefits,...

The workplace environment and doctors’ health

1 July 2017 | | URO - Core Urology
It is well established that doctors have higher levels of stress, depression and suicide than the general population [1] and most other professional groups. In addition they have high levels of ‘burnout’. Research indicates that although burnout is correlated with...

22 Weymouth Street

6 November 2020 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This year, 2020, is the 75th anniversary of the formation of BAUS. It...

Testicular cancer: management of stage I seminoma

1 July 2014 | | URO - Urologic Oncology
Introduction Testicular cancer is the most frequently occurring solid tumour in men between the ages of 15 and 34 years [1]. About 60% of cases are seminomas and approximately 70-80% of them have, at presentation, clinical stage I disease. This...